Page 11 - Revista SPORL - Vol 58. Nº2
P. 11

TABLE 2
Characteristics of patients with stroke after SHL.

Patient  Gender  Age  Affected ear                             SHL   Stroke  Evolution time (yr)  Stroke subtype a
   1      Male                                                       2002              6                 SAO
   2      Male   73                                 Right      1996  2004              10                 LAA
   3     Female                                                      2014              6                  SIC
   4     Female  90                                 Bilateral  1994  2011              8                 SAO
   5     Female                                                      1995              1                  CE
   6      Male   46 Left 2008                                        2015              20                SAO
   7      Male                                                       2011              14                SAO
                 88                                 Bilateral  2003

                 75                                 Right      1994                                                                     ARTIGO ORIGINAL ORIGINAL ARTICLE

                 57 Left 1995

                 69 Left 1997

aAccording to Lausanne Stroke Registry classification10: LAA, large-artery atherosclerosis; CE, cardioembolism; SAO, lacunar stroke or
small-artery occlusion; SIC, stroke of other infrequent cause.

stroke (secondary outcome analysis). All of the patients       increase the risk of stroke during the observation time
included in the secondary outcome analysis presented           period of 6 years.
some cardiovascular disease risk factors (Figure 1). Table     In the present study stroke was reported between 1
1 shows the clinical characteristics and comorbidities         and 20 years after SHL. Therefore, the risk for a stroke
in patients with SHL in different series and the present       remains for several years after an episode of SHL. Two
study. Stroke was reported in 21 patients: 7 (10.94 %)         patients with bilateral SHL had a stroke during follow-
of the SHL patients and 14 (5.46 %) from the control           up. Conversely, none of the patients with bilateral SHL
cohort. SHL patients had significantly lower stroke-           experienced a stroke in Chang et al. study6.
free survival rates than de control subjects (p < 0.01).
According to Lausanne Stroke Registry classification 10,       Although the mechanisms responsible of the
lacunar stroke or small-artery occlusion (SAO) was the         relationship between SHL and the subsequent stroke
most frequent form of stroke presentation.                     have to be elucidated, elevated plasma fibrinogen and
The majority of cases occurred within the first 10 years       cholesterol could have a role since they can contribute
after SHL, although two cases occurred at 14 and 20            to atherosclerosis and thrombosis19,20. Cholesterol may
years. Two patients with bilateral SHL had a stroke            impair cochlear vascularization by reducing the release
during follow-up (Table 2).                                    of nitric oxide from endothelial cells and it can also
                                                               diminishes motility of outer hair cells21. Since fibrinogen
DISCUSSION                                                     increases plasma viscosity and induces aggregation
The present study try to consider the risk of stroke within    of erythrocytes, thrombocytes, and leucocytes, it
patients in the long-term follow-up after hospitalization      may also reduce cochlear blood flow22. Fibrinogen/
for an acute SHL episode.                                      LDL apheresis has been reported to be effective in
Age above 65 years, hypertension, coronary artery              treatment of SHL since it may reduce the concentration
disease, and history of stroke have been reported as risk      of serum LDL, lipoprotein and fibrinogen23. Glycoprotein
factors for stroke after SHL5-8. These are also risk factors   polymorphisms associated to elevated fibrinogen
for stroke in the general population11,12. Patent foramen      concentration have been reported in SHL patients24. The
ovale has also been suggested as a cardiovascular risk         C807T glycoprotein polymorphism has proved to be a
factor associated with stroke and SHL13-18.                    risk factor for SHL and stroke19,25,26.
Previous studies reported that the probability of stroke       The inner ear is especially sensitive to ischemia.
was 1.64 times5, 2.02 times7 and 1.22 times8 higher            Impaired blood flow in the labyrinthine artery is
in SHL patients. Moreover, 12.7% of the SHL patients           regulated by plasma viscosity and adrenergic receptors.
had a stroke and almost 50% of patients presented              Studies suggest a vascular origin in SHL27. Some authors
stroke within 2 years after the SHL5. Kim et al.7 found        found a high incidence of cardiovascular risk factors in
that SHL was associated with increased incidence of            their sample28. However, the lack of a clear relationship
cardiocerebrovascular disease, specifically stroke. Kim        between SHL and cardiovascular risk factors might
et al.8 found that SHL increased the risk of ischemic          suggest a multifactorial origin28.
stroke, but not hemorrhagic stroke.                            The small number of patients affected by SHL of unknown
However, other studies concluded that SHL did not              cause who presented cardiovascular disease risk factors
increase the risk of stroke. Chang et al.6 divided SHL         is a limitation in the present study. Data from this study
patients into a stroke group and a non-stroke group and        suggest a vascular origin of SHL of unknown cause in
its features were compared but there is not a control          a group of patients with subsequent development of
group. Ciorba et al.11 found that SHL did not significantly    stroke in a small percentage of them.

                                                                             VOL 58 . Nº2 . JUNHO 2020 59
   6   7   8   9   10   11   12   13   14   15   16